Duopharma Biotech Berhad: Employees Provident Fund Board Acquires Additional Shares

Strategic Insights -

Duopharma Biotech Berhad, a Malaysian-based pharmaceutical company, has witnessed a significant change in its shareholding structure with the Employees Provident Fund Board (EPF) acquiring additional shares. EPF, a substantial shareholder, has increased its stake in the company through Citigroup Nominees (Tempatan) Sdn. Bhd., its nominee. This acquisition highlights the interest of Malaysian state-backed pension funds in the local pharmaceutical industry.

The EPF has acquired 429,000 ordinary shares in Duopharma Biotech Berhad, bringing its total stake to 83,845,795 shares, representing approximately 8.72% of the company's issued shares. This acquisition demonstrates the EPF's confidence in the company's growth prospects and its commitment to investing in the Malaysian pharmaceutical sector.

Key Takeaways:

  • Duopharma Biotech Berhad has received a notice from Citigroup Nominees (Tempatan) Sdn. Bhd. on behalf of the Employees Provident Fund Board (EPF) regarding the acquisition of 429,000 ordinary shares.
  • The acquisition brings the total number of Duopharma Biotech Berhad shares held by EPF nominee, Citigroup Nominees (Tempatan) Sdn. Bhd., to 83,845,795 shares.
  • The EPF's stake in Duopharma Biotech Berhad now represents approximately 8.72% of the company's issued shares.
  • The acquisition highlights the interest of Malaysian state-backed pension funds in the local pharmaceutical industry.
  • Duopharma Biotech Berhad has a diverse stakeholder base, with multiple nominees holding shares on behalf of EPF.
  • The company's shareholding structure has undergone significant changes over the past year.

Statistics:

  • 429,000: Number of ordinary shares acquired by Citigroup Nominees (Tempatan) Sdn. Bhd. on behalf of EPF.
  • 83,845,795: Total number of Duopharma Biotech Berhad shares held by Citigroup Nominees (Tempatan) Sdn. Bhd. on behalf of EPF.
  • 8.72%: Percentage of Duopharma Biotech Berhad's issued shares held by EPF through Citigroup Nominees (Tempatan) Sdn. Bhd.
  • 52 million: Total number of Duopharma Biotech Berhad shares outstanding.

Sources:

  • Bursa Malaysia Stock Exchange website
  • Duopharma Biotech Berhad's website